Industry News
Pharmaceutical Industry News
Some Immune Systems Defeat Cancer. Could That Become a Drug?
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a treatment could be difficult.
As Lindsey Vonn’s comeback run…
As Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the professional skier to its team, too.
The project, which involves Merck,…
The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT Biologika, aims to make Merck's current Ebola vaccine easier to manufacture and store, prompting broader global accessibility.
Despite falling short in its…
Despite falling short in its recent bid to snatch Avadel from Alkermes, Lundbeck is signaling to investors that it’s not desperate for deals and will not lower its standards for future M&A transactions.
Fierce’s Zoey Becker, Angus Liu…
Fierce’s Zoey Becker, Angus Liu and Gabrielle Masson unpack the key topics and trends that stood out at this year’s J.P. Morgan Healthcare Conference.
After U.S. President Donald Trump…
After U.S. President Donald Trump took the stage at the World Economic Forum this week to tout the supposed success of his tariff-tinged trade negotiations, the French presidency has pushed back against a drug pricing
CDMO Samsung Biologics grew sales…
CDMO Samsung Biologics grew sales more than 30% last year to around 4.6 trillion Korean won ($3.1 billion) and lifted its 2025 operating profit to roughly 2.07 trillion won ($1.4 billion). Samsung Bio is now
Executives from top U.S….
Executives from top U.S. biosimilar makers are optimistic about the future of U.S. biosimilar adoption as recent FDA guidance seeks to streamline biosimilar development and potentially dissipate the upcoming “biosimilar void.”
Is Your Medicine Cabinet a Mess?
Here’s what to toss, what to keep and how to store your drugs safely.
In Johnson & Johnson’s…
In Johnson & Johnson's long-running talc litigation, a court-appointed special master has recommended that plaintiffs should be able to present testimony from expert witnesses who can speak to scientific evidence backing their claims. The decision
Led by cancer standout Darzalex,…
Led by cancer standout Darzalex, Johnson & Johnson projects that its 2026 revenue will reach between $100 billion and $101 billion. With J&J also forecasting double-digit revenue increases by the end of the decade, the
The company announced a phase 3…
The company announced a phase 3 win in the rare neurodegenerative disease Ataxia-Telangiectasia on the same day it snagged a key European approval in the drug's original indication of Niemann-Pick disease type C.
While much of the biopharma…
While much of the biopharma industry has spent the past 12 months treading lightly around the Trump administration and the tumult it has wrought on U.S. medical research and regulation, Pfizer’s CEO cut to the
Curia Global is laying off 81…
Curia Global is laying off 81 employees as part of its plan to shut down its drug product development and manufacturing facility in Burlington, Massachusetts, according to a Worker Adjustment and Retraining Notification.
GSK, through its oncology…
GSK, through its oncology subsidiary Tesaro, is handing over $20 million upfront to Alteogen for global rights to the Korean biotech’s novel hyaluronidase ALT-B4. Tesaro plans to use ALT-B4 to develop and potentially market a
Takeda is executing another round…
Takeda is executing another round of layoffs, cutting 243 roles in the United States. The company is preparing for an upcoming patent loss on depression drug Trintellix.
Roche is more than doubling its…
Roche is more than doubling its total commitment to a future facility for its Genentech unit to approximately $2 billion. The plant, being built in Holly Springs, North Carolina, will be used to crank out
As it inches closer to FDA…
As it inches closer to FDA submissions for its psychedelic drug candidate, Definium Therapeutics is laying the groundwork for a future launch with an educational push about the pharmaceutical potential of LSD.
The U.S. Supreme Court will hear a…
The U.S. Supreme Court will hear a case involving the "skinny label" practice of generic drugmakers, with its review particularly relating to Hikma's marketing of its generic version of Amarin's Vascepa.
9 mitos sobre la salud de las mujeres
Cuando se trata de la salud del corazón, la inmunidad, la reproducción y otros aspectos, abundan las ideas falsas.